Blueberry Therapeutics have unique nanopolymer drug delivery technology... ...which opens up huge opportunities to rapidly develop new medicines... ...and helps us find ways to treat dermatological disorders.
Written by Dr Heather Davies-Strickleton, Senior Analytical Scientist Now a new year is here we start to take a [...]
Ryan Gibson2020-01-11T19:41:57+00:00January 10th, 2020|
A Blueberry case study
In this video, CEO John Ridden and CSO David Cook talk about the early days of Blueberry Therapeutics, the short term and long term plans for the company, and the benefits of being based at Alderley Park, Cheshire.